Guo-Qing Jiang Selected Research

Splenectomy

10/2022	Clinical effects of cluster technology optimization and innovations on laparoscopic splenectomy and azygoportal disconnection: a single-center retrospective study with 500 consecutive cases.
10/2022	Robotic-assisted versus laparoscopic approach of Bai-Jiang-style vagus nerve-preserving splenectomy and azygoportal disconnection.
1/2022	Predictors of portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection in hepatitis B cirrhosis: a prospective study.
11/2021	Novel noninvasive liver fibrotic markers to predict postoperative re-bleeding after laparoscopic splenectomy and azygoportal disconnection: a 1-year prospective study.
11/2020	Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study.
4/2019	Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial.
1/2019	Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection.
11/2018	Laparoscopic splenectomy and azygoportal disconnection combining with pre- and postoperative endoscopic intervention - A sandwich-style sequential therapy for portal hypertensive bleeding: A retrospective cohort study.
2/2017	Individualized Laparoscopic Therapy for Portal Hypertension: A Preliminary Single Center Experience.
1/2017	Laparoscopic and Open Splenectomy and Hepatectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Qing Jiang Research Topics

Disease

12	Fibrosis (Cirrhosis) 10/2022 - 04/2012
12	Hypersplenism (Anemia, Splenic) 10/2022 - 01/2014
10	Hemorrhage 10/2022 - 01/2014
10	Portal Hypertension 10/2022 - 01/2014
8	Neoplasms (Cancer) 01/2022 - 08/2014
7	Flatulence 10/2022 - 04/2012
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2012
7	Thrombosis (Thrombus) 01/2022 - 10/2015
4	Pain (Aches) 10/2022 - 01/2014
2	Fever (Fevers) 01/2022 - 10/2016
2	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 01/2014
2	Postoperative Hemorrhage 11/2018 - 10/2015
2	Ovarian Epithelial Carcinoma 11/2008 - 04/2008
1	Down Syndrome (Down's Syndrome) 01/2022
1	Hepatitis B 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Carcinogenesis 01/2020
1	Lymphatic Metastasis 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Varicose Veins (Varicose Vein) 02/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Hemangioma (Angioma) 11/2015
1	Infections 10/2015
1	Pleural Effusion (Pleural Effusions) 10/2015
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Granuloma 08/2014
1	Necrosis 08/2014
1	Adenocarcinoma 11/2008
1	Ovarian Neoplasms (Ovarian Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

11	Lysergic Acid Diethylamide (LSD)IBA 10/2022 - 10/2015
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 07/2016
2	Biological FactorsIBA 08/2021 - 01/2021
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 10/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019 - 07/2016
1	BuffersIBA 01/2022
1	Circular RNAIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CM 2-3IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	UbiquitinIBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	GlutaminaseIBA 08/2019
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	Serum AlbuminIBA 01/2018
1	ProcalcitoninIBA 10/2016
1	C-Reactive ProteinIBA 10/2016
1	Hemoglobins (Hemoglobin)IBA 12/2014
1	Pharmaceutical PreparationsIBA 08/2014
1	Fluorouracil (Carac)FDA LinkGeneric 08/2014
1	liposomal doxorubicin (Doxil)FDA Link 11/2008
1	1-dodecylpyridoxal (PLD)IBA 11/2008
1	Carboplatin (JM8)FDA LinkGeneric 11/2008

Therapy/Procedure

17	Splenectomy 10/2022 - 01/2014
10	Length of Stay 10/2022 - 04/2012
4	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2014
3	Therapeutics 11/2018 - 07/2016
3	Hepatectomy 02/2017 - 11/2015
2	Operative Surgical Procedures 01/2021 - 01/2014
1	Ligation 11/2018
1	Autologous Blood Transfusion 12/2014
1	Drug Therapy (Chemotherapy) 08/2014
1	Fluid Therapy (Oral Rehydration Therapy) 04/2012
1	Neoadjuvant Therapy 04/2008
1	Adjuvant Chemotherapy 04/2008
1	Cytoreduction Surgical Procedures 04/2008